- ￥900 - 2800
- Sino Biological
- 北京
- 10445-MM02-A
- 2025年08月12日
- FCM
- Mouse
- Human
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human FLT3 / CD135 / FLK2 protein (Catalog#10445-H08H)
- 亚型：
Mouse IgG1
- 形态：
液体
- 保存条件：
-20℃ 至 -80℃
- 克隆性：
单克隆
- 标记物：
APC
- 适应物种：
Human
- 保质期：
12个月
- 抗原来源：
10445-H08H
- 目录编号：
10445-MM02-A
- 级别：
免疫学试剂
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 宿主：
Mouse
- 应用范围：
FCM
- 靶点：
FLT3
- 抗体英文名：
FLT3 / CD135 / FLK2 Antibody (APC), Mouse MAb
- 抗体名：
FLT3 / CD135 / FLK2 Antibody (APC), Mouse MAb
- 规格：
25 Tests/100 Tests
| 规格： | 25 Tests | 产品价格： | ￥900.0 |
|---|---|---|---|
| 规格： | 100 Tests | 产品价格： | ￥2800.0 |
FLT3|FLT3 antibody|FLT3抗体|Anti-Human 鼠单抗（产品说明）
抗体种属：Human
抗体靶点：FLT3
抗体应用：FCM
抗原货号：10445-H08H
抗原描述：Recombinant Human FLT3 / CD135 / FLK2 protein (Catalog#10445-H08H)
抗体宿主：Mouse
抗体Ig类型：Mouse IgG1
抗体纯化方法：Protein A
抗体标记：APC
抗体制备：This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human FLT3 / CD135 / FLK2 (rh FLT3 / CD135 / FLK2; Catalog#10445-H08H; NP_004110.2; Met 1-Asn 541) and conjugated with APC under optimum conditions, the unreacted APC was removed.
抗体特异性：Human FLT3 / CD135 / FLK2
抗体保存：This antibody can be stored at 2℃-8℃ for twelve months without detectable loss of activity. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验a simple ELISA method to detect human anti-antibody response.
Immunohistochemistry: Mouse Anti-Human MCP-1
. 4. Incubate the tissue section overnight at 4?C with Mouse Anti-Human MCP-1 at 10.0 μg/mL. Wash the slide twice for three minutes each. 5. Incubate the tissue section with the Envision HRP polymer kit (Dako) according to the manufacturer’s
FLT3 Mutations in Acute Myeloid Leukemia
The prevalence of an internal tandem duplication (ITD) of the juxtamembrane domain-coding sequence and a missense mutation of D835 within the kinase domain of the FLT3 gene is 15–35% and 5–10% of adults with acute myeloid leukemia (AML
技术资料暂无技术资料 索取技术资料
